All Trilipix Options Available To Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
ACCORD-Lipid trial results could lead members to recommend conducting another trial, revising the label, withdrawing the indication or take no action for Trilipix coadministration with a statin.